Literature DB >> 6380855

The blast cells of acute myeloblastic leukaemia.

E A McCulloch.   

Abstract

Cell culture methods are available that permit colony formation by the normal progenitors of myelopoiesis and lymphopoiesis. The blast cells of acute myeloblastic leukaemia may also form colonies under selective conditions in culture. It is feasible, therefore, to determine some of the properties of blast progenitors. These were found to be uniformly in active cell cycle. However, great patient-to-patient variation was seen in the sensitivity of blast progenitors to chemotherapeutic agents and in their capacity to undergo self-renewal. The latter attribute, but not the former, was correlated with clinical outcome. These culture findings were used to propose a model of AML that includes an increase in diversity with malignant transformation. The model finds further support from studies of the phenotypes of blast cells freshly obtained from AML patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380855

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


  4 in total

1.  Ultrastructural features of acute monoblastic leukaemia cells: a multivariate morphometric analysis.

Authors:  V James; D A Winfield; N T James
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

2.  Clonogenic growth of acute non-lymphocytic leukemia cells in serum-free medium.

Authors:  P A Bernabei; V Santini; O Dal Pozzo; R Bezzini; V Gattei; R Saccardi; G Rombolà; P R Ferrini
Journal:  Experientia       Date:  1988-10-15

3.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.

Authors:  S Seremetis; J Cuttner; R Winchester
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

4.  Identification of a role for the nuclear receptor EAR-2 in the maintenance of clonogenic status within the leukemia cell hierarchy.

Authors:  C V Ichim; H L Atkins; N N Iscove; R A Wells
Journal:  Leukemia       Date:  2011-06-03       Impact factor: 11.528

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.